期刊文献+

Lucentis和Avastin治疗激光诱导恒河猴脉络膜新生血管模型的作用 被引量:5

Therapeutic effects of Avastin and Lucentis on laser-induced choroidal neovascularization in rhesus monkeys
下载PDF
导出
摘要 目的通过激光诱导恒河猴眼底脉络膜新生血管(choroidal neovascularization,CNV)的形成,建立和人CNV类似的动物模型,用于定量评价Lucentis和Avastin治疗激光诱导引起的CNV的效果。方法采用眼科激光光凝仪围绕恒河猴黄斑中心凹进行光凝造模。光凝后21 d进行眼底荧光血管造影检查,根据荧光渗漏面积将动物分为空白对照组(生理盐水)、Avastin组(每眼1.25 mg)、Lucentis组(每眼0.5mg),均玻璃体内单次注射给药。给药后13 d、28 d进行眼底彩色照相、眼底荧光血管造影、光学相干断层扫描检查,给药后29 d摘取眼球进行病理学检查。结果与空白对照组相比,Avastin组在给药后13 d和28 d,荧光渗漏面积改善率分别为56.1%和82.0%,与空白对照组相比差异均有显著统计学意义(均为P<0.01),视网膜厚度改善率分别为14.2%和14.8%,与空白对照组相比差异均有显著统计学意义(均为P<0.01);Lucentis组在给药后13 d和28 d,荧光渗漏面积改善率分别为66.2%和75.6%,与空白对照组相比差异均有显著统计学意义(均为P<0.01),视网膜厚度改善率分别为19.8%和18.0%,与空白对照组相比差异均有显著统计学意义(均为P<0.01)。结论 Avastin和Lucentis对激光所致的猴眼底CNV均有明显的抑制作用。 Objective To establish an experimental model of choroidal neovascularization( CNV) through laser injury in the eyes of rhesus monkey,and quantitatively evaluate the therapeutic effects of Lucentis and Avastin on laser-induced CNV. Methods CNV model was induced by laser photocoagulation of the central macular fovea in rhesus monkeys,and confirmed by fluorescence fundus angiography( FFA) at 21 days post-exposure. According to the area of fluorescence leakage,monkeys were divided into three groups: Control group,Avastin( 1. 25 mg per eye) group and Lucentis( 0. 5mg per eye) group,and the drugs were single intravitreally injected. The fundus color photography,FFA and coherence tomography( OCT) were conducted at 13 days and28 days after giving drugs. Eyeballs were obtained and histopathology analysis was completed at 29 days after giving drugs. R esults Compared with the control group,the improvement rates of fluorescence leakage area at 13 days and 28 days after giving drugs in Avastin group were 56. 1 % and 82. 0 %,respectively,which in Lucentis group were 66. 2 % and 75. 6 %,respectively,there were significant differences compared with the control group( all P 〈0. 01). Compared with the control group,the improvement rates of retinal thickness at 13 days and 28 days after giving drugs in Avastin group were 14. 2 % and 14. 8 %,respectively,which in Lucentis group were 19. 8 %and 18. 0 %,respectively,there were significant differences compared with the control group( all P 〈0. 01). Conclusion Avastin and Lucentis can all obviously inhibit the laser-induced CNV in rhesus monkeys.
出处 《眼科新进展》 CAS 北大核心 2016年第5期423-427,共5页 Recent Advances in Ophthalmology
基金 科技部科技型中小企业技术创新基金(编号:14C26215102969) 四川省科技计划项目青年基金(编号:2015JQO059) 四川省科技计划项目支撑计划(编号:2015SZ0012)~~
关键词 AVASTIN LUCENTIS 脉络膜新生血管 激光 恒河猴 Avastin Lucentis choroidal neovascularization Rhesus monkeys
  • 相关文献

参考文献12

  • 1MARKUN S, DISHY A, NEUNER-JEHI S, ROSEMANN T, FREI A. The chronic care for wet age related macular degen- eration (CHARMED) study: A randomized controlled trial [J].PLoS One,2015,10( 11 ) :e0143085.
  • 2KANO M, SEKIRYU T, SUGANO Y, OGUCHI Y, OJIMA A, ITA- GAKI K, et al. Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degener-ation[J]. Clin Ophthalmo1,2015 ,9 :2049-2056.
  • 3赖坤贝,金陈进,涂姝,熊云帆,黄蕊,葛坚.激光诱导的恒河猴脉络膜新生血管模型的研究[J].中华眼科杂志,2014,50(3):203-208. 被引量:3
  • 4GOODY R J, HU W, SHAFIEE A, STRUHARIK M, BARTELS S, LOPEZ FJ, et al. Optimization of laser-induced choroidal neovascularization in African green monkeys [J].Exp Eye Res,2011,92( 6 ) :464-472.
  • 5LU F,ADELMAN RA. Are intravitreal bevacizumab and ranib- izumab effective in a rat model of choroidal neovasculariza- tion[J]. ? C, mefes Arch Clin Exp Ophthalmo/,2009,247 (2) : 171-177.
  • 6GHARBIYA M, GIUSTOLISI R,ALLrEVI F, FANTOZZI N,MA77ZEO L,SCAVELLA V,et al. Choroidal neovascularization in patho- logic myopia:intravitreal ranibizumab versus bevacizumab--a randomized controlled trial [ J ]. Am J Ophthalmol, 2010,149 ( 3 ) :458-464.
  • 7ZHANG M, ZHANG J, YAN M, LI H, YANG C, YU D. Recombi- nant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys [ J]. Mol Via ,2008,14( 1 ) :37-49.
  • 8ZHAO T, ZHANG J, ZHANG Y, HUANG J, WANG X, ZHANG Y,et al. Vascular endothelial growth factor receptor 2 anti- body, BC001, attenuates laser-induced choroidal neovaseu- larization in Rhesus monkeys ( Macaca mulatta) [J]. J Ocul Pha~ol Tker,2015,31 (10) :611-616.
  • 9KOCH S, CLAESSON-Welsh L. Signal transduction by vascu- lax endothelial growth factor receptors [J].Cold Spring Harb Perspect Med,2012,2( 7 ) : a006502.
  • 10ROY H, BHARDWAJ S, Y1A-Herttuala S. Biology of vascular endothelial growth factors [J]. FEBS Left, 2005,580 ( 12 ) : 2879-2887.

二级参考文献12

  • 1陈有信,葛坚,严密,金陈进,张美霞,董方田,陆方,张承芬,赵家良.中国维替泊芬光动力疗法治疗年龄相关性黄斑变性中心凹下脉络膜新生血管的多中心临床研究[J].中华眼科杂志,2007,43(3):198-205. 被引量:35
  • 2唐仕波,梁小玲,胡洁,丁小燕,万婷,郭梦翔,胡忆群.玻璃体腔注射bevacizumab治疗年龄相关性黄斑变性的初步临床观察[J].中华眼科杂志,2007,43(10):890-896. 被引量:13
  • 3Lee P , Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review[J]. Surv Ophthalmol, 1998 ,43 :245-269.
  • 4Ryan S1. The development of an experimental model of subretinal neovascularization in disciform macular degeneration[J] . Trans Am Ophthalmol Soc, 1979,77 :707-745.
  • 5Krzystolik M G, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti?vascular endothelial growth factor antibody fragment[J]. Arch Ophthalmol ,2002,120 :338-346.
  • 6FrancoisJ, De LaeyJ J, Cambie E, et al. Neovascularization after argon laser photocoagulation of macular lesions[J]. AmJ Ophthalmol, 1975,79 :206-210.
  • 7Fine SL, Patz A, Orth DH, et al. Subretinal neovascularization developing after prophylactic argon laser photocoagulation of atrophic macular scars[J]. AmJ Ophthalmol,1976,82:352-357.
  • 8Dobi ET, Puliafito CA, Destro M. A new model of experimental choroidal neovascularization in the rat[J]. Arch Ophthalmol, 1989 , 107 : 264-269.
  • 9Lu F, Adelman RA. Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization[J] ? Graefes Arch Clin Exp Ophthalmol, 2009 ,247 : 171-177.
  • 10Ryan S]. Subretinal neovascularization. Natural history of an experimental model[J]. Arch Ophthalmol, 1982,100: 1804-1809.

共引文献2

同被引文献32

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部